Nijmegen Centre for Mitochondrial Disorders at the Department of Pediatrics, Radboud University Nijmegen Medical Centre, The Netherlands.
Cell Metab. 2010 Sep 8;12(3):283-94. doi: 10.1016/j.cmet.2010.08.002.
Acyl-CoA dehydrogenase 9 (ACAD9) is a recently identified member of the acyl-CoA dehydrogenase family. It closely resembles very long-chain acyl-CoA dehydrogenase (VLCAD), involved in mitochondrial beta oxidation of long-chain fatty acids. Contrary to its previously proposed involvement in fatty acid oxidation, we describe a role for ACAD9 in oxidative phosphorylation. ACAD9 binds complex I assembly factors NDUFAF1 and Ecsit and is specifically required for the assembly of complex I. Furthermore, ACAD9 mutations result in complex I deficiency and not in disturbed long-chain fatty acid oxidation. This strongly contrasts with its evolutionary ancestor VLCAD, which we show is not required for complex I assembly and clearly plays a role in fatty acid oxidation. Our results demonstrate that two closely related metabolic enzymes have diverged at the root of the vertebrate lineage to function in two separate mitochondrial metabolic pathways and have clinical implications for the diagnosis of complex I deficiency.
酰基辅酶 A 脱氢酶 9(ACAD9)是酰基辅酶 A 脱氢酶家族的新成员。它与长链酰基辅酶 A 脱氢酶(VLCAD)非常相似,后者参与长链脂肪酸的线粒体β氧化。与之前提出的参与脂肪酸氧化相反,我们描述了 ACAD9 在氧化磷酸化中的作用。ACAD9 结合复合物 I 组装因子 NDUFAF1 和 Ecsit,并且是复合物 I 组装所必需的。此外,ACAD9 突变导致复合物 I 缺乏,而不是干扰长链脂肪酸氧化。这与它的进化祖先 VLCAD 形成鲜明对比,我们表明 VLCAD 不是复合物 I 组装所必需的,并且显然在脂肪酸氧化中发挥作用。我们的结果表明,两种密切相关的代谢酶在脊椎动物谱系的根部发生分歧,以在两个独立的线粒体代谢途径中发挥作用,并对复合物 I 缺乏症的诊断具有临床意义。